Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
Cumberland's Acetadote sNDA approved by FDA enhances IV administration process. Acetadote addresses acetaminophen overdose, a major cause of liver failure. New dosing regimen reduces medication errors and improves patient outcomes. Cumberland's Q3 revenues fell to $9.1 million from $10.1 million year-on-year. CPIX stock surged 142.7% to $3.01 following FDA approval.
View signal analysis